M.A. Postow

Discipline

Economies et finances (1)

Type de document

Co-auteur

J.D. Wolchok

F.S. Hodi

R.J. Sullivan

G.K. Schwartz

E. Romano

C. Robert

S. Re

N. Ramaiya

D. Paulucci

P.A. Ott

O. Michielin

J.J. Luke

D.P. Lawrence

J. Larkin

N. Ibrahim

K. Homicsko

C. Hoeller

J.J. Harding

A. Giobbie-Hurder

K.T. Flaherty

R. Dummer

D. Dobler

M. Dickson

D'Angelo, S.

P.B. Chapman

R.D. Carvajal

M.K. Callahan

M. Bluth

V. Atkinson

P.A. Ascierto

Date

Source

Serveur académique Lausannois (2)

Mot-clé

thérapie (2) analyse (2) taux (2) survie (2) Treatment (2) Therapeutics (2) Survival (2) Patients (2) Months (2) Melanoma (2) Analysis (2) Patients (2) toxicité (1) norme (1) étable (1) pompe (1) protéine (1) association (1) anticorps (1) hôpital (1) danger (1) Europe (1) dose (1) maladie (1) cancer (1) Europe (1) Lausanne (1) Cancer (1) Care (1) Inhibitors (1)

Documents écrit par M.A. Postow (2) | parle de M.A. Postow (0)

Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma.

K. Homicsko et al. (5 mai 2022)

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

J.J. Luke et al. (2013)